Tags

Type your tag names separated by a space and hit enter

Photocoagulation for retinal vein occlusion.
Prog Retin Eye Res. 2021 Mar 11 [Online ahead of print]PR

Abstract

The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974. The most serious complications of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are: (i) visual deterioration, most commonly due to macular edema, and (ii) the development of ocular neovascularization (NV), particularly neovascular glaucoma (NVG), with hazardous consequences for vision and even the eye itself. Before discussing the role of photocoagulation in the management of NV and macular edema in RVO, it is crucial to gain a basic scientific understanding of the following relevant issues: classification of RVO, ocular NV in RVO, and the natural history of macular edema and visual outcome of RVO. These topics are discussed. In CRVO, ocular NV is a complication of ischemic CRVO but not of nonischemic CRVO. Photocoagulation has been advocated to prevent and/or treat the development of ocular NV and NVG. Since NVG is the most dreaded, intractable and blinding complication of ischemic CRVO, the role of photocoagulation and its management are discussed. Findings of three randomized, prospective clinical trials dealing with photocoagulation in ischemic CRVO are discussed. The role of photocoagulation in the management of ocular NV and macular edema in BRVO, and three randomized, prospective clinical trials dealing with those are discussed. Recent advent of intravitreal anti-VEGF and corticosteroid therapies has drastically changed the role of photocoagulation in the management of macular edema and NV in CRVO and BRVO. This is discussed in detail.

Authors+Show Affiliations

Department of Ophthalmology and Visual Sciences, College of Medicine, University of Iowa, Iowa City, IA, USA. Electronic address: sohan-hayreh@uiowa.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33713810

Citation

Hayreh, Sohan Singh. "Photocoagulation for Retinal Vein Occlusion." Progress in Retinal and Eye Research, 2021, p. 100964.
Hayreh SS. Photocoagulation for retinal vein occlusion. Prog Retin Eye Res. 2021.
Hayreh, S. S. (2021). Photocoagulation for retinal vein occlusion. Progress in Retinal and Eye Research, 100964. https://doi.org/10.1016/j.preteyeres.2021.100964
Hayreh SS. Photocoagulation for Retinal Vein Occlusion. Prog Retin Eye Res. 2021 Mar 11;100964. PubMed PMID: 33713810.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Photocoagulation for retinal vein occlusion. A1 - Hayreh,Sohan Singh, Y1 - 2021/03/11/ PY - 2021/01/15/received PY - 2021/03/03/revised PY - 2021/03/04/accepted PY - 2021/3/14/pubmed PY - 2021/3/14/medline PY - 2021/3/13/entrez KW - Anti-VEGF therapy KW - Branch retinal vein occlusion KW - Central retinal vein occlusion KW - Corticosteroid therapy KW - Hemi-central retinal vein occlusion KW - Laser photocoagulation KW - Macular edema KW - Neovascular glaucoma KW - Ocular neovascularization KW - Panretinal photocoagulation KW - Photocoagulation KW - Retinal vein occlusion SP - 100964 EP - 100964 JF - Progress in retinal and eye research JO - Prog Retin Eye Res N2 - The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974. The most serious complications of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are: (i) visual deterioration, most commonly due to macular edema, and (ii) the development of ocular neovascularization (NV), particularly neovascular glaucoma (NVG), with hazardous consequences for vision and even the eye itself. Before discussing the role of photocoagulation in the management of NV and macular edema in RVO, it is crucial to gain a basic scientific understanding of the following relevant issues: classification of RVO, ocular NV in RVO, and the natural history of macular edema and visual outcome of RVO. These topics are discussed. In CRVO, ocular NV is a complication of ischemic CRVO but not of nonischemic CRVO. Photocoagulation has been advocated to prevent and/or treat the development of ocular NV and NVG. Since NVG is the most dreaded, intractable and blinding complication of ischemic CRVO, the role of photocoagulation and its management are discussed. Findings of three randomized, prospective clinical trials dealing with photocoagulation in ischemic CRVO are discussed. The role of photocoagulation in the management of ocular NV and macular edema in BRVO, and three randomized, prospective clinical trials dealing with those are discussed. Recent advent of intravitreal anti-VEGF and corticosteroid therapies has drastically changed the role of photocoagulation in the management of macular edema and NV in CRVO and BRVO. This is discussed in detail. SN - 1873-1635 UR - https://www.unboundmedicine.com/medline/citation/33713810/Photocoagulation_for_retinal_vein_occlusion. L2 - https://linkinghub.elsevier.com/retrieve/pii/S1350-9462(21)00025-2 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.